Postprandial Glucose Control Using the Medtronic Advanced Hybrid Closed-Loop System: Faster-Acting Insulin Aspart vs. Insulin Aspart

被引：1
|
作者：
Lee, Melissa H.
Vogrin, Sara
Paldus, Barbora
Morrison, Dale
Zaharieva, Dessi
Lu, Jean
Jones, Hannah
Wyatt, Sue A.
Netzer, Emma
Sims, Catriona M.
Macisaac, Richard
Grosman, Benyamin
Roy, Anirban
Kurtz, Natalie
Jenkins, Alicia
Oneal, David N.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-234-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234-OR
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
    Bode, Bruce W.
    Johnson, Joseph A.
    Hyveled, Liselotte
    Tamer, Soren C.
    Demissie, Marek
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (01) : 25 - +
  • [22] Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus
    Fath, Maryam
    Danne, Thomas
    Biester, Torben
    Erichsen, Lars
    Kordonouri, Olga
    Haahr, Hanne
    PEDIATRIC DIABETES, 2017, 18 (08) : 903 - 910
  • [23] Higher Early Exposure and Greater Early Glucose-lowering Effect with Faster-Acting Insulin Aspart vs. Insulin Aspart in Japanese Patients with T1D
    Shiramoto, Masanari
    Nishida, Tomoyuki
    Hansen, Ann Kathrine
    Haahr, Hanne
    DIABETES, 2015, 64 : A249 - A249
  • [24] Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in Japanese patients with type 1 diabetes
    Shiramoto, M.
    Nishida, T.
    Hansen, A.
    Haahr, H.
    DIABETOLOGIA, 2015, 58 : S403 - S403
  • [25] Earlier Onset and Higher Early Exposure of Faster-Acting Insulin Aspart vs. Insulin Aspart in Adults Is Retained in Children and Adolescents with T1D
    Danne, Thomas
    Biester, Torben
    Fath, Maryam
    Thorsson, Lars
    Rikte, Tord
    Kordonouri, Olga
    Haahr, Hanne
    DIABETES, 2015, 64 : A247 - A247
  • [26] Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study
    Ozer, Kerem
    Cooper, Alison M.
    Ahn, Lily P.
    Waggonner, Cassidy R.
    Blevins, Thomas C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (04) : 286 - 292
  • [27] Short-term fully closed-loop insulin delivery using faster insulin aspart compared with standard insulin aspart in type 2 diabetes
    Bally, Lia
    Herzig, David
    Ruan, Yue
    Wilinska, Malgorzata E.
    Semmo, Mariam
    Vogt, Andreas
    Wertli, Maria M.
    Vogt, Bruno
    Stettler, Christoph
    Hovorka, Roman
    DIABETES OBESITY & METABOLISM, 2019, 21 (12): : 2718 - 2722
  • [28] Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in elderly and younger adults with type 1 diabetes
    Hovelmann, U.
    Zijlstra, E.
    Stender-Petersen, K.
    Jacobsen, J. B.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2015, 58 : S450 - S450
  • [29] Faster-Acting Insulin Aspart vs. Insulin Aspart as Part of Basal-Bolus Therapy Improves Postprandial Glycemic Control in Uncontrolled T2D in the Double- Blinded Onset® 2 Trial
    Bowering, Keith
    Case, Christopher
    Harvey, John
    Reeves, Michael
    Sampson, Mike
    Strzinek, Robert
    Bretler, Ditte-Marie
    Bang, Rikke Beck
    Bode, Bruce W.
    DIABETES, 2016, 65 : A63 - A63
  • [30] FAST-ACTING INSULIN ASPART COMPARED WITH RAPID-ACTING INSULIN ANALOGS IN THE ADVANCED HYBRID CLOSED-LOOP SYSTEM IN ADULTS WITH TYPE 1 DIABETES
    Amuedo, S.
    Herguido, N. Gros
    Bellido, V.
    Gallardo, G. Lopez
    Vinau, F. Losada
    Morales, A. Perez
    Moreno, A. Soto
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A104 - A105
12345